We are live on ! Find out more
HA

HC Advisors Portfolio holdings

AUM $149M
1-Year Est. Return 17.72%
This Fund
S&P 500
This Quarter Est. Return
+12.38%
1 Year Est. Return
+17.72%
3 Year Est. Return
+55.19%
5 Year Est. Return
+59.33%
10 Year Est. Return
AUM
$146M
AUM Growth
+$22.3M
Cap. Flow
+$8.81M
Cap. Flow %
6.02%
Top 10 Hldgs %
63.19%
Holding
90
New
14
Increased
37
Reduced
17
Closed
3

Sector Composition

Rank Sector Weight
1 Healthcare 5.26%
2 Technology 2.83%
3 Materials 1.38%
4 Communication Services 1.22%
5 Consumer Discretionary 1.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RETA
26
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$921K 0.63%
7,450
-124
-2% -$16.3K
AMZN icon
27
Amazon
AMZN
$2.53T
$899K 0.61%
5,520
+240
+5% +$38.3K
VOO icon
28
Vanguard S&P 500 ETF
VOO
$972B
$876K 0.6%
2,548
VBR icon
29
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.2B
$855K 0.58%
6,012
ALXO icon
30
ALX Oncology
ALXO
$262M
$845K 0.58%
9,803
+3,300
+51% +$199K
PSLV icon
31
Sprott Physical Silver Trust
PSLV
$12.2B
$829K 0.57%
88,706
+800
+0.9% +$6.87K
HD icon
32
Home Depot
HD
$332B
$748K 0.51%
2,815
-447
-14% -$123K
SRPT icon
33
Sarepta Therapeutics
SRPT
$1.64B
$730K 0.5%
4,282
+515
+14% +$76.3K
PAAS icon
34
Pan American Silver
PAAS
$18.6B
$681K 0.47%
19,742
-985
-5% -$31.8K
PDX
35
PIMCO Dynamic Income Strategy Fund
PDX
$945M
$678K 0.46%
83,918
+1,650
+2% +$12K
TGTX icon
36
TG Therapeutics
TGTX
$8.19B
$668K 0.46%
+12,834
New +$434K
VEA icon
37
Vanguard FTSE Developed Markets ETF
VEA
$230B
$657K 0.45%
13,924
CRSP icon
38
CRISPR Therapeutics
CRSP
$4.77B
$646K 0.44%
4,218
+388
+10% +$45.9K
CYTK icon
39
Cytokinetics
CYTK
$10.9B
$617K 0.42%
+29,692
New +$543K
IWF icon
40
iShares Russell 1000 Growth ETF
IWF
$120B
$533K 0.36%
8,840
VTWG icon
41
Vanguard Russell 2000 Growth ETF
VTWG
$1.48B
$500K 0.34%
2,398
KL
42
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$483K 0.33%
11,703
+320
+3% +$14.2K
VCIT icon
43
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.3B
$481K 0.33%
4,949
KO icon
44
Coca-Cola
KO
$381B
$466K 0.32%
8,494
+34
+0.4% +$1.76K
VBK icon
45
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.2B
$455K 0.31%
1,699
MSFT icon
46
Microsoft
MSFT
$3.35T
$447K 0.31%
2,008
AEM icon
47
Agnico Eagle Mines
AEM
$75.4B
$446K 0.3%
6,325
+261
+4% +$19.5K
VTHR icon
48
Vanguard Russell 3000 ETF
VTHR
$4.65B
$444K 0.3%
2,550
GOOGL icon
49
Alphabet (Google) Class A
GOOGL
$4.08T
$421K 0.29%
+4,800
New +$404K
ASND icon
50
Ascendis Pharma A/S
ASND
$16.5B
$416K 0.28%
2,497
+192
+8% +$31.8K

Similar funds

HC Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, HC Advisors held 90 positions worth $146M, up 18% from $124M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

HC Advisors deployed $8.81M of net new capital in Q4 2020, opening 14 new positions and adding to 37 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 3,463 shares worth $1.29M.

By sector, the portfolio is most concentrated in Healthcare at 5.3% of assets, up from 3.7% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Schwab Intermediately-Term US Treasury ETF, an estimated $764K trimmed.

  • HC Advisors's largest Q4 2020 buy was State Street SPDR S&P 500 ETF Trust: 3,463 shares worth $1.29M.
  • HC Advisors added most to First Trust Morningstar Dividend Leaders Index Fund in Q4 2020, an estimated $2.35M increase.
  • HC Advisors's biggest Q4 2020 reduction was Schwab Intermediately-Term US Treasury ETF, cutting an estimated $764K.
  • HC Advisors fully exited ProShares UltraPro Short S&P 500 in Q4 2020, selling an estimated $339K.
  • HC Advisors's ten largest holdings make up 63% of its $146M portfolio in Q4 2020.
  • HC Advisors opened 14 new positions and closed 3 in Q4 2020.
  • HC Advisors's portfolio value rose 18% quarter-over-quarter to $146M.

Based on HC Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.